Porphyromonas gingivalis

NOVATO, California, July 13, 2026 Lighthouse Pharmaceuticals has announced new clinical findings from its Phase 2/3 GAIN trial, demonstrating...

Boston, Massachusetts, November 26, 2025 — Lighthouse Pharmaceuticals announced that it will present new clinical and mechanistic updates for...